Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Seizures × 1 year × Clear all

Phase

Phase 3 2 Phase 2 2 Phase NA 1 Phase 4 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 47 Prostatic Neoplasms 22 Neoplasms 19 Multiple Myeloma 16 Papillomavirus Infections 12 Carcinoma, Non-Small-Cell Lung 12 Carcinoma, Hepatocellular 12 Stomach Neoplasms 11 Colorectal Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lung Neoplasms 9 Pain, Postoperative 8 Neoplasm Metastasis 8 Recurrence 7 Ovarian Neoplasms 7 Waldenstrom Macroglobulinemia 6 Polycystic Ovary Syndrome 6 Melanoma 6 Hematologic Neoplasms 6 Lymphoma, Non-Hodgkin 5 Lymphoma, Follicular 5 Leukemia, Myeloid, Acute 5 Leiomyoma 5 Kidney Neoplasms 5 Agnosia 5 Venous Thromboembolism 4 Urinary Bladder Neoplasms 4 Thyroid Neoplasms 4 Smoking Cessation 4 Pain 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05864846 2026-03-12

EpiCom

Jazz Pharmaceuticals

Phase 4 Active not recruiting

Behavior, Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡